RECURRENT SALIVARY GLAND CARCINOMA
Clinical trials for RECURRENT SALIVARY GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT SALIVARY GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT SALIVARY GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hormone therapy duo takes on rare salivary cancer
Disease control OngoingThis study tests two drugs that block male hormones to slow or shrink a rare type of salivary gland cancer that has spread or come back. About 21 people whose cancer has not been treated with hormone therapy before will take darolutamide (a pill) and leuprolide (an injection). Th…
Matched conditions: RECURRENT SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Could a Blood-Flow blocker boost chemo for head and neck cancer?
Disease control OngoingThis study tested whether adding the drug bevacizumab to standard chemotherapy helps people with head and neck cancer that has returned or spread. About 400 adults took part. The goal was to see if the combination helped them live longer. Bevacizumab works by cutting off the tumo…
Matched conditions: RECURRENT SALIVARY GLAND CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThis study tests whether combining the chemotherapy drug pemetrexed with the immunotherapy drug pembrolizumab can shrink or control advanced salivary gland cancer that has returned or spread. About 45 adults with this rare cancer will receive the combination treatment. The goal i…
Matched conditions: RECURRENT SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:02 UTC